72.30EUR+1.12%Mkt Cap: 825.35M EURP/E: 14.37Last update: 2026-05-14
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offer…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)14.37
P/E (Forward)12.53
PEG3.80
P/B1.47
P/S1.57
EV/EBITDA—
EV/Revenue—
EPS (TTM)4.94
EPS (Forward)5.67
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF72.08M EUR
CapEx (TTM)20.73M EUR
Net Debt/EBITDA—
Net Debt—
Technical
SMA 5078.30 (-7.7%)
SMA 20078.76 (-8.2%)
Beta0.90
S&P 52W Chg24.23%
Avg Vol (30d)2.42K
Avg Vol (10d)2.93K
Technical Indicators
RSI (14)34.7
MACD-2.0563
MACD Signal-1.4299
MACD Hist.-0.6264
BB Upper85.08 EUR
BB Middle77.39 EUR
BB Lower69.71 EUR
BB Width19.86%
ATR (14)2.233 EUR
Vol Ratio (20d)2.04x
52W Range
68.7016% of range91.50
52W High91.50 EUR
52W Low68.70 EUR
Profitability
Gross Margin74.73%
EBITDA Margin21.57%
Profit Margin10.91%
Oper. Margin16.25%
ROE9.70%
ROA7.51%
Revenue Growth-2.40%
Earnings Growth—
Balance Sheet
Debt/Equity0.03
Current Ratio—
Quick Ratio—
Book Value/Sh48.21 EUR
Cash/Share—
Dividends
Fwd Div Rate0.8900 EUR
Trail. Div Rate0.9300 EUR
Div. Yield1.25%
5Y Avg Yield0.85%
Payout Ratio18.02%
Ex-Div DateJun 4, 2025
Pay Date—
Ownership
Shares Out.11.62M
Float—
Insiders67.01%
Institutions13.42%
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)89.30 EUR
Target Range80.00 EUR – 110.00 EUR
# Analysts5
Company
Market Cap825.35M EUR
Enterprise Value—
Revenue (TTM)525.70M EUR
Gross Profit392.83M EUR
Net Income (TTM)57.36M EUR
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price72.30 EUR
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0004186856